| 上皮间质转化促乳腺癌机制及药物干预治疗研究进展 |
| |
| 引用本文： | 林昌杰,李婷,唐鑫,陈颖钰,郭爱珍,胡长敏.上皮间质转化促乳腺癌机制及药物干预治疗研究进展[J].中国畜牧兽医,2021(1). |
| |
| 作者姓名： | 林昌杰 李婷 唐鑫 陈颖钰 郭爱珍 胡长敏 |
| |
| 作者单位： | 华中农业大学动物医学院;华中农业大学 |
| |
| 基金项目： | 国家重点研发计划(2016YFD0500906);国家现代农业(肉牛/牦牛)产业技术体系(CARS-37);国家自然科学基金项目(31972758);中央高校基本科研业务费专项基金(2662020DKPY014);全国农业科研杰出人才基金。 |
| |
| 摘 要： | 乳腺癌是犬、猫等伴侣动物与人类常发疾病,作为人类及动物常患恶性肿瘤和主要致死肿瘤之一,其疾病负担仍呈逐步加重趋势,乳腺癌的预防及治疗形势愈加严峻。上皮间质转化(EMT)是乳腺癌发生发展中重要的生物学过程。EMT还可促进恶性肿瘤的侵袭、扩散及耐药,因此它在肿瘤的研究中日益受到关注,靶向于EMT是治疗乳腺癌的重要研究方向与热点。文章就EMT发生过程中细胞形态功能及标志物的变化、EMT分类及EMT与乳腺癌的关系分别展开论述,详细解析了EMT相关TGF-β/Smad、NF-κB及Wnt信号通路转导途径;随后对乳腺癌治疗药物研究进展,包括TGF-β/Smad通路抑制剂开发,相关药物、基因及细胞因子治疗前景、NF-κB通路与Wnt通路抑制剂的动物试验研究结果进行了详细论述;最后对乳腺癌的治疗发展与趋势进行了展望。深入认识信号通路调控乳腺癌EMT的生物学过程,明确其发生发展机制,寻找关键靶点及开发靶向药物,将为乳腺癌的精准治疗带来曙光。
|
| 关 键 词： | 乳腺癌 上皮间质转化 靶向治疗 TGF-Β/SMAD NF-κB WNT |
Advances in the Mechanism of Epithelial-mesenchymal Transition for Breast Cancer Promotion and Drug Intervention |
| |
| LIN Changjie,LI Ting,TANG Xin,CHEN Yingyu,GUO Aizhen,HU Changmin.Advances in the Mechanism of Epithelial-mesenchymal Transition for Breast Cancer Promotion and Drug Intervention[J].China Animal Husbandry & Veterinary Medicine,2021(1). |
| |
| Authors: | LIN Changjie LI Ting TANG Xin CHEN Yingyu GUO Aizhen HU Changmin |
| |
| Institution: | (College of Veterinary Medicine,Huazhong Agricultural University, Wuhan 430070,China;State Key Laboratory of Agricultural Microbiology,Huazhong Agricultural University,Wuhan 430070, China) |
| |
| Abstract: | Breast cancer is a common disease in dogs,cats and other companion animals and humans.As a malignant tumor and the main cause of death of humans and animals,the disease burden of breast cancer is still gradually increasing,and the prevention and treatment situation of breast cancer is becoming more and more serious.Epithelial-mesenchymal transition(EMT)plays an important role in biological process in the development of breast cancer,which can also promote the invasion,metastasis and drug resistance of malignant tumors.Therefore,it is getting more and more attention in cancer research,and targeting EMT is an important research direction and hotspot in the treatment of breast cancer.In this paper,the changes of cell morphology and function and markers,the classification of EMT and the relationship between EMT and breast cancer were discussed respectively.The EMT-related TGF-β/Smad,NF-κB and Wnt signaling pathways were analyzed in detail.And then advances in the treatment of breast cancer,including the development of inhibitors of TGF-β/Smad pathway,the prospect of treatment with related drugs,genes and cytokines,and the experimental results of NF-κB pathway and Wnt pathway inhibitors,were discussed in detail.Finally,the development and trend of the treatment of breast cancer were prospected.Deeply understanding the biological process of breast cancer EMT regulated by signaling pathway,making clear its occurrence development mechanism,finding key targets and developing targeted drugs,will bring the dawn for the precise treatment of breast cancer. |
| |
| Keywords: | breast cancer epithelial-mesenchymal transition targeted therapy TGF-β/Smad NF-κB Wnt |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
